Dobutamine 12.5mg/ml Sterile Concentrate Malta - angleščina - Medicines Authority

dobutamine 12.5mg/ml sterile concentrate

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Dobutamine Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

dobutamine

rex medical ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml;   - concentrate for infusion - 250 mg/20ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml   excipient: hydrochloric acid sodium hydroxide sodium metabisulfite water for injection - dobutamine is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive ?- adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially noncardiac in origin 1. acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure 2. low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock.

DOBUTAMINE 12.5 Mg/Ml Concentrate for Soln for Inf Irska - angleščina - HPRA (Health Products Regulatory Authority)

dobutamine 12.5 mg/ml concentrate for soln for inf

claris lifesciences (uk) limited - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml - adrenergic and dopaminergic agents

DOBUTAMINE-HAMELN 250 MG/20 ML AMPOULE 12.5 Mg/Ml Concentrate for Soln for Inf Irska - angleščina - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/20 ml ampoule 12.5 mg/ml concentrate for soln for inf

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

DOBUTAMINE-HAMELN 250 MG/ 5 ML AMPOULE 50 Mg/Ml Concentrate for Soln for Inf Irska - angleščina - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 5 ml ampoule 50 mg/ml concentrate for soln for inf

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 50 mg/ml

DOBUTAMINE-HAMELN 250 MG/ 50 ML VIAL 5 Mg/Ml Solution for Infusion Irska - angleščina - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 50 ml vial 5 mg/ml solution for infusion

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

DOBUTAMINE-HAMELN 250 MG/50 ML AMPOULE 5 Mg/Ml Solution for Infusion Irska - angleščina - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/50 ml ampoule 5 mg/ml solution for infusion

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

STERILE DOBUTAMINE HYDROCHLORIDE CONCENTRATE Irska - angleščina - HPRA (Health Products Regulatory Authority)

sterile dobutamine hydrochloride concentrate

hospira uk limited - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml - dobutamine

Dobutamine 250mg/20ml concentrate for solution for infusion ampoules Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

dobutamine 250mg/20ml concentrate for solution for infusion ampoules

hameln pharma ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml

DBL™ Dobutamine Hydrochloride Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

dbl™ dobutamine hydrochloride

pfizer new zealand limited - dobutamine hydrochloride 12.5 mg/ml - solution for injection - 12.5 mg/ml - active: dobutamine hydrochloride 12.5 mg/ml excipient: sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. (refer to the data sheet for conditions which may precipitate such situations).